Meridian Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Sell |
1,335
-59
| -4% | -$23.9K | 0.09% | 118 |
|
|
2025
Q1 | $694K | Sell |
1,394
-260
| -16% | -$129K | 0.12% | 92 |
|
|
2024
Q4 | $861K | Hold |
1,654
| – | – | 0.14% | 85 |
|
|
2024
Q3 | $1.02M | Sell |
1,654
-7
| -0.4% | -$4.33K | 0.17% | 79 |
|
|
2024
Q2 | $919K | Buy |
1,661
+7
| +0.4% | +$3.87K | 0.16% | 85 |
|
|
2024
Q1 | $961K | Hold |
1,654
| – | – | 0.18% | 84 |
|
|
2023
Q4 | $878K | Hold |
1,654
| – | – | 0.19% | 84 |
|
|
2023
Q3 | $837K | Buy |
1,654
+40
| +2% | +$20.2K | 0.21% | 82 |
|
|
2023
Q2 | $842K | Hold |
1,614
| – | – | 0.2% | 82 |
|
|
2023
Q1 | $930K | Hold |
1,614
| – | – | 0.23% | 80 |
|
|
2022
Q4 | $889K | Sell |
1,614
-133
| -8% | -$73.2K | 0.23% | 81 |
|
|
2022
Q3 | $886K | Buy |
1,747
+1
| +0.1% | +$507 | 0.25% | 77 |
|
|
2022
Q2 | $949K | Buy |
1,746
+623
| +55% | +$339K | 0.25% | 80 |
|
|
2022
Q1 | $664K | Buy |
1,123
+643
| +134% | +$380K | 0.15% | 111 |
|
|
2021
Q4 | $321K | Buy |
480
+7
| +1% | +$4.68K | 0.08% | 156 |
|
|
2021
Q3 | $270K | Hold |
473
| – | – | 0.08% | 163 |
|
|
2021
Q2 | $239K | Sell |
473
-43
| -8% | -$21.7K | 0.07% | 177 |
|
|
2021
Q1 | $236K | Sell |
516
-1,520
| -75% | -$695K | 0.08% | 159 |
|
|
2020
Q4 | $948K | Sell |
2,036
-10
| -0.5% | -$4.66K | 0.35% | 66 |
|
|
2020
Q3 | $903K | Sell |
2,046
-90
| -4% | -$39.7K | 0.39% | 58 |
|
|
2020
Q2 | $774K | Buy |
2,136
+384
| +22% | +$139K | 0.36% | 63 |
|
|
2020
Q1 | $497K | Buy |
1,752
+186
| +12% | +$52.8K | 0.27% | 74 |
|
|
2019
Q4 | $509K | Buy |
1,566
+13
| +0.8% | +$4.23K | 0.2% | 92 |
|
|
2019
Q3 | $452K | Buy |
+1,553
| New | +$452K | 0.19% | 98 |
|
|
2019
Q1 | – | Sell |
-53
| Closed | -$12K | – | 363 |
|
|
2018
Q4 | $12K | Buy |
+53
| New | +$12K | 0.01% | 392 |
|